How should I dilute a 25 mg (5 mL) nitroglycerin ampule for IV infusion to obtain a 100 µg/mL concentration and what infusion rate provides the standard starting dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin IV Dilution and Infusion Protocol

To achieve a 100 µg/mL concentration from your 25 mg (5 mL) ampule, add the entire ampule to 245 mL of either D5W or 0.9% NaCl to create a total volume of 250 mL, then start the infusion at 5 µg/min (3 mL/hr) using non-absorbing tubing. 1

Dilution Preparation

  • Add the complete 25 mg nitroglycerin ampule (5 mL) to 245 mL of diluent to achieve a final volume of 250 mL with a concentration of 100 µg/mL 1
  • Acceptable diluents: Either Dextrose 5% Injection or Sodium Chloride 0.9% Injection 1
  • Critical safety warning: Never administer nitroglycerin as a direct IV injection—it must be diluted prior to infusion 1
  • Do not mix nitroglycerin with other drugs in the same solution 1
  • Invert the container several times after adding the nitroglycerin to ensure uniform dilution 1

Starting Infusion Rate

  • Initial dose: 5 µg/min when using non-absorbing (non-PVC) tubing 1
  • At 100 µg/mL concentration, this equals 3 mL/hr on a volumetric infusion pump 1
  • Important context: Historical studies used PVC tubing and started at 25 µg/min or higher, but PVC absorbs significant amounts of nitroglycerin, requiring higher doses 1
  • Modern non-absorbing tubing delivers drug more efficiently, necessitating lower starting doses to avoid hypotension 1

Titration Algorithm

  • Increase by 5 µg/min increments every 3-5 minutes until you observe a partial blood pressure response 1
  • Once reaching 20 µg/min without response, you may increase increments to 10 µg/min, then 20 µg/min 1
  • After observing partial response: Reduce the increment size and lengthen the interval between increases 1
  • Maximum concentration: Do not exceed 400 µg/mL if you need to concentrate the solution for fluid restriction 1
  • Critical equipment note: If you change the concentration, you must flush or replace the entire infusion set before using the new concentration to avoid delayed delivery 1

Special Patient Considerations

  • Angina patients without heart failure may be hypersensitive and respond fully to doses as low as 5 µg/min, requiring especially careful titration 1
  • Recent evidence suggests high-dose strategies (≥100 µg/min) achieve blood pressure targets faster in acute pulmonary edema (57% reaching target within 1 hour vs 22% with low-dose), though this requires careful monitoring 2
  • The European Society of Cardiology recommends nitroglycerin as a vasodilator option in acute heart failure with adequate blood pressure (SBP >85 mmHg) 3

Mandatory Monitoring Requirements

  • Continuous blood pressure and heart rate monitoring in all patients 1
  • Pulmonary capillary wedge pressure monitoring when appropriate 1
  • Stop nitroglycerin immediately if systolic blood pressure drops below 85 mmHg 3
  • Maintain adequate systemic blood pressure and coronary perfusion pressure throughout infusion 1

Common Pitfalls to Avoid

  • Using PVC tubing without dose adjustment: PVC absorbs 40-80% of nitroglycerin, leading to underdosing if you use non-PVC starting doses 1
  • Failing to flush tubing after concentration changes: The old concentration can remain in the dead space for minutes to hours depending on flow rate, causing unpredictable dosing 1
  • Inadequate monitoring: Nitroglycerin has no fixed optimal dose—each patient requires individual titration based on hemodynamic response 1
  • Mixing with other medications: This can cause incompatibilities and unpredictable drug delivery 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.